A randomized, double-blind, placebo-controlled trial to assess prevention of mood episodes with risperidone long-acting injectable in patients with bipolar I disorder

A randomized, double-blind, placebo-controlled trial to assess prevention of mood episodes with risperidone long-acting injectable in patients with bipolar I disorder

The efficacy and safety of risperidone long acting injectable (LAI) for preventing recurrence of mood episodes in patient with bipolar| disorder was evaluated in a randomized, placebocontrolled study. After a 12 week pen label period with risperidone LAI (n=560), patient who did not experience a rec...

Full description

Saved in:
Bibliographic Details
Main Authors: Vieta, E., Montgomery, S., Sulaiman, A.H., Cordoba, R., Huberlant, B., Martinez, L., Schreiner, A.
Format: Article
Language:English
Published: Elsevier 2012
Subjects:
R Medicine
Online Access:http://eprints.um.edu.my/9627/1/00000797_93580.pdf
http://eprints.um.edu.my/9627/
Tags: Add Tag
No Tags, Be the first to tag this record!
Institution: Universiti Malaya
Language: English

Internet

http://eprints.um.edu.my/9627/1/00000797_93580.pdf
http://eprints.um.edu.my/9627/

Similar Items